Laura Stein
CIK 1199099 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 28 Agu 2008 · Terbaru: 28 Agu 2008
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 5 Nov. 2020 | CLX | S | 19.430 | $215,46 | $4.186.388 | 40.325 Langsung | -32,52% | Dilepas | -49,9% (harga per 2026-08-19) |
| 3 Nov. 2020 | CLX | S | 8.570 | $212,19 | $1.818.468 | 59.755 Langsung | -12,54% | Dilepas | -49,1% (harga per 2026-08-19) |
| 31 Agu 2018 | CLX | S | 12.880 | $144,10 | $1.856.008 | 61.603 Langsung | -17,29% | Dilepas | -25,1% (harga per 2026-08-19) |
| 2 Sep. 2016 | CLX | S | 38.882 | $131,69 | $5.120.371 | 50.569 Langsung | -43,47% | Dilepas | -18,0% (harga per 2026-08-19) |
Menampilkan 100 dari 238 transaksi terakhir
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 17 Maret 2025 | MDLZ | Stock Options (right to buy) | Class A Common Stock (35.750) | $65,09 | 17 Maret 2035 | 35.750 | Diakuisisi |
| 2 Maret 2023 | MDLZ | Stock Options (right to buy) | Class A Common Stock (36.340) | $65,36 | 2 Maret 2033 | 36.340 | Diakuisisi |
| 24 Feb. 2022 | MDLZ | Stock Options (right to buy) | Class A Common Stock (34.810) | $64,65 | 24 Feb. 2032 | 34.810 | Diakuisisi |
| 18 Feb. 2021 | MDLZ | Stock Options (right to buy) | Class A Common Stock (40.090) | $56,13 | 18 Feb. 2031 | 40.090 | Diakuisisi |
| 11 Jan. 2021 | MDLZ | Stock Options (right to buy) | Class A Common Stock (48.170) | $57,09 | 11 Jan. 2031 | 48.170 | Diakuisisi |
| 4 Jan. 2021 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (781) | — | 20 Jan. 2047 | 781 | Diakuisisi |
| 1 Okt. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (950) | — | 20 Jan. 2047 | 950 | Diakuisisi |
| 22 Sep. 2020 | CLX | Stock Option (Right to Buy) | Common Stock (8.584) | $212,38 | 22 Sep. 2030 | 8.584 | Diakuisisi |
| 1 Juli 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (941) | — | 20 Jan. 2047 | 941 | Diakuisisi |
| 1 Juli 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (4.035) | — | 20 Jan. 2047 | 4.035 | Diakuisisi |
| 1 April 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (1.198) | — | 20 Jan. 2047 | 1.198 | Diakuisisi |
| 15 Feb. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (96) | — | 20 Jan. 2047 | 96 | Diakuisisi |
| 11 Feb. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3.180) | — | 20 Jan. 2047 | 3.180 | Diakuisisi |
| 10 Feb. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (59) | — | 20 Jan. 2047 | 59 | Diakuisisi |
| 29 Jan. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (30) | — | 20 Jan. 2047 | 30 | Diakuisisi |
| 22 Jan. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (97) | — | 20 Jan. 2047 | 97 | Diakuisisi |
| 2 Jan. 2020 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (537) | — | 20 Jan. 2047 | 537 | Diakuisisi |
| 10 Des. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (15) | — | 20 Jan. 2047 | 15 | Diakuisisi |
| 9 Des. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (14) | — | 20 Jan. 2047 | 14 | Diakuisisi |
| 20 Nov. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (46) | — | 20 Jan. 2047 | 46 | Diakuisisi |
| 8 Nov. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (13) | — | 20 Jan. 2047 | 13 | Diakuisisi |
| 24 Okt. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (13) | — | 20 Jan. 2047 | 13 | Diakuisisi |
| 20 Okt. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (14) | — | 20 Jan. 2047 | 14 | Diakuisisi |
| 1 Okt. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (246) | — | 20 Jan. 2047 | 246 | Diakuisisi |
| 17 Sep. 2019 | CLX | Stock Option (Right to Buy) | Common Stock (31.221) | $155,54 | 17 Sep. 2029 | 31.221 | Diakuisisi |
| 29 Juli 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (11) | — | 20 Jan. 2047 | 11 | Diakuisisi |
| 1 Juli 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (196) | — | 20 Jan. 2047 | 196 | Diakuisisi |
| 11 Juni 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (22) | — | 20 Jan. 2047 | 22 | Diakuisisi |
| 25 April 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (11) | — | 20 Jan. 2047 | 11 | Diakuisisi |
| 2 April 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (11) | — | 20 Jan. 2047 | 11 | Diakuisisi |
| 1 April 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (204) | — | 20 Jan. 2047 | 204 | Diakuisisi |
| 12 Feb. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (1.164) | — | 20 Jan. 2047 | 1.164 | Diakuisisi |
| 11 Feb. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (25) | — | 20 Jan. 2047 | 25 | Diakuisisi |
| 28 Jan. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (12) | — | 20 Jan. 2047 | 12 | Diakuisisi |
| 2 Jan. 2019 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (230) | — | 20 Jan. 2047 | 230 | Diakuisisi |
| 10 Des. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (47) | — | 20 Jan. 2047 | 47 | Diakuisisi |
| 8 Nov. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (47) | — | 20 Jan. 2047 | 47 | Diakuisisi |
| 24 Okt. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (53) | — | 20 Jan. 2047 | 53 | Diakuisisi |
| 22 Okt. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (52) | — | 20 Jan. 2047 | 52 | Diakuisisi |
| 1 Okt. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (902) | — | 20 Jan. 2047 | 902 | Diakuisisi |
| 18 Sep. 2018 | CLX | Stock Option (Right to Buy) | Common Stock (24.640) | $151,85 | 18 Sep. 2028 | 24.640 | Diakuisisi |
| 31 Agu 2018 | CLX | Stock Option (Right to Buy) | Common Stock (13.650) | $72,11 | 11 Sep. 2022 | 13.650 | Dilepas |
| 26 Juli 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (46) | — | 20 Jan. 2047 | 46 | Diakuisisi |
| 2 Juli 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (870) | — | 20 Jan. 2047 | 870 | Diakuisisi |
| 11 Juni 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (87) | — | 20 Jan. 2047 | 87 | Diakuisisi |
| 25 April 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (45) | — | 20 Jan. 2047 | 45 | Diakuisisi |
| 11 April 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (46) | — | 20 Jan. 2047 | 46 | Diakuisisi |
| 2 April 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (822) | — | 20 Jan. 2047 | 822 | Diakuisisi |
| 14 Feb. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3.642) | — | 20 Jan. 2047 | 3.642 | Diakuisisi |
| 29 Jan. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (33) | — | 20 Jan. 2047 | 33 | Diakuisisi |
| 2 Jan. 2018 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (549) | — | 20 Jan. 2047 | 549 | Diakuisisi |
| 11 Des. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (34) | — | 20 Jan. 2047 | 34 | Diakuisisi |
| 9 Nov. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (36) | — | 20 Jan. 2047 | 36 | Diakuisisi |
| 25 Okt. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (34) | — | 20 Jan. 2047 | 34 | Diakuisisi |
| 22 Okt. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (34) | — | 20 Jan. 2047 | 34 | Diakuisisi |
| 2 Okt. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (531) | — | 20 Jan. 2047 | 531 | Diakuisisi |
| 12 Sep. 2017 | CLX | Stock Option (Right to Buy) | Common Stock (32.750) | $135,57 | 12 Sep. 2027 | 32.750 | Diakuisisi |
| 27 Juli 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (33) | — | 20 Jan. 2047 | 33 | Diakuisisi |
| 3 Juli 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (527) | — | 20 Jan. 2047 | 527 | Diakuisisi |
| 13 Juni 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (68) | — | 20 Jan. 2047 | 68 | Diakuisisi |
| 27 April 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (35) | — | 20 Jan. 2047 | 35 | Diakuisisi |
| 12 April 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (37) | — | 20 Jan. 2047 | 37 | Diakuisisi |
| 3 April 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (569) | — | 20 Jan. 2047 | 569 | Diakuisisi |
| 15 Feb. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3.160) | — | 20 Jan. 2047 | 3.160 | Diakuisisi |
| 14 Feb. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (71) | — | 20 Jan. 2047 | 71 | Diakuisisi |
| 26 Jan. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (37) | — | 20 Jan. 2047 | 37 | Diakuisisi |
| 3 Jan. 2017 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (587) | — | 20 Jan. 2047 | 587 | Diakuisisi |
| 12 Des. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (38) | — | 20 Jan. 2047 | 38 | Diakuisisi |
| 10 Nov. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (40) | — | 20 Jan. 2047 | 40 | Diakuisisi |
| 25 Okt. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (43) | — | 20 Jan. 2047 | 43 | Diakuisisi |
| 17 Okt. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (44) | — | 20 Jan. 2047 | 44 | Diakuisisi |
| 3 Okt. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (655) | — | 20 Jan. 2047 | 655 | Diakuisisi |
| 13 Sep. 2016 | CLX | Stock Option (Right to Buy) | Common Stock (30.020) | $123,09 | 13 Sep. 2026 | 30.020 | Diakuisisi |
| 2 Sep. 2016 | CLX | Stock Option (Right to Buy) | Common Stock (40.950) | $72,11 | 11 Sep. 2022 | 40.950 | Dilepas |
| 27 Juli 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (43) | — | 20 Jan. 2047 | 43 | Diakuisisi |
| 1 Juli 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (718) | — | 20 Jan. 2047 | 718 | Diakuisisi |
| 14 Juni 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (46) | — | 20 Jan. 2047 | 46 | Diakuisisi |
| 13 Juni 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (45) | — | 20 Jan. 2047 | 45 | Diakuisisi |
| 26 April 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (37) | — | 20 Jan. 2047 | 37 | Diakuisisi |
| 1 April 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (602) | — | 20 Jan. 2047 | 602 | Diakuisisi |
| 17 Feb. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3.649) | — | 20 Jan. 2047 | 3.649 | Diakuisisi |
| 16 Feb. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (89) | — | 20 Jan. 2047 | 89 | Diakuisisi |
| 2 Feb. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (47) | — | 20 Jan. 2047 | 47 | Diakuisisi |
| 4 Jan. 2016 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (656) | — | 20 Jan. 2047 | 656 | Diakuisisi |
| 19 Nov. 2015 | CLX | Stock Option (Right to Buy) | Common Stock (14.747) | $68,15 | 13 Sep. 2021 | 14.747 | Dilepas |
| 11 Nov. 2015 | CLX | Stock Option (Right to Buy) | Common Stock (17.577) | $68,15 | 13 Sep. 2021 | 17.577 | Dilepas |
| 4 Nov. 2015 | CLX | Stock Option (Right to Buy) | Common Stock (8.716) | $68,15 | 13 Sep. 2021 | 8.716 | Dilepas |
| 15 Sep. 2015 | CLX | Stock Option (Right to Buy) | Common Stock (30.420) | $111,60 | 15 Sep. 2025 | 30.420 | Diakuisisi |
| 29 Juli 2015 | CLX | Stock Option (Right to Buy) | Common Stock (45.080) | $66,48 | 14 Sep. 2020 | 45.080 | Dilepas |
| 11 Maret 2015 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (483) | — | 20 Jan. 2047 | 483 | Diakuisisi |
| 2 Jan. 2015 | CLX | Stock Option (Right to Buy) | Common Stock (44.240) | $57,25 | 15 Sep. 2019 | 44.240 | Dilepas |
| 29 Des. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (9) | — | 20 Jan. 2047 | 9 | Diakuisisi |
| 22 Des. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3) | — | 20 Jan. 2047 | 3 | Diakuisisi |
| 3 Des. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3) | — | 20 Jan. 2047 | 3 | Diakuisisi |
| 11 Nov. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3) | — | 20 Jan. 2047 | 3 | Diakuisisi |
| 7 Nov. 2014 | CLX | Stock Option (Right to Buy) | Common Stock (20.000) | $61,16 | 18 Sep. 2017 | 20.000 | Dilepas |
| 7 Nov. 2014 | CLX | Stock Option (Right to Buy) | Common Stock (38.350) | $63,95 | 16 Sep. 2018 | 38.350 | Dilepas |
| 24 Okt. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3) | — | 20 Jan. 2047 | 3 | Diakuisisi |
| 20 Okt. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (3) | — | 20 Jan. 2047 | 3 | Diakuisisi |
| 1 Okt. 2014 | BEN | Deferred Director's Fees (FRI) | Common Stock, par value $.10 (39) | — | 20 Jan. 2047 | 39 | Diakuisisi |
Menampilkan 100 dari 160 transaksi terakhir
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 4 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $632.461 | — | — | — | $315.168 | $787.857 | $133.721 | $2.968.869 |
| 2018 | $607.288 | — | — | — | $321.300 | — | $177.933 | $2.106.867 |
| 2016 | $582.050 | — | — | — | $754.980 | $862.607 | $226.861 | $3.226.049 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.